Gastroesophageal Adenocarcinoma Completed Phase 2 Trials for OSI-7904L (DB05457)

IndicationStatusPhase
DBCOND0030813 (Gastroesophageal Adenocarcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00073502Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) CancerTreatment